84-5959-71　MAPKAPK5 100ug　568165

特徴

• Tumor suppressor serine/threonine-protein kinase involved in mTORC1signaling and post-transcriptional regulation.
• Phosphorylates FOXO3,ERK3/MAPK6, ERK4/MAPK4, HSP27/HSPB1, p53/TP53 and RHEB.
• Acts as a tumor suppressor by mediating Ras-induced senescence and phosphorylating p53/TP53.
• Involved in post-transcriptional regulation of MYC by mediating phosphorylation of FOXO3: phosphorylation of FOXO3 leads to promote nuclear localization of FOXO3, enabling expression of miR-34b and miR-34c, 2 posttranscriptional regulators of MYC that bind to the 3'UTR of MYC transcript and prevent MYC translation.
• Acts as a negative regulator of mTORC1 signaling by mediating phosphorylation and inhibition of RHEB.
• Part of the atypical MAPK signaling via its interaction with ERK3/MAPK6 or ERK4/MAPK4: the precise role of the complex formed with ERK3/MAPK6 or ERK4/MAPK4 is still unclear, butthe complex follows a complex set of phosphorylation events: upon interaction with atypical MAPK (ERK3/MAPK6 or ERK4/MAPK4), ERK3/MAPK6 (or ERK4/MAPK4) is phosphorylated and then mediates phosphorylation and activation of MAPKAPK5, which in turn phosphorylates ERK3/MAPK6 (or ERK4/MAPK4).
• Mediates phosphorylation of HSP27/HSPB1 in response toPKA/PRKACA stimulation, inducing F-actin rearrangement.
• Applications:Suitable for use in ELISA and Immunofluorescence.
• Other applications not tested.
• Recommended Dilution:Immunofluorescence: 1:200-1:500Optimal dilutions to be determined by the researcher.
• Storage and Stability:May be stored at 4°C for short-term only.
• Aliquot to avoid repeated freezing and thawing.
• Store at -20°C.
• Aliquots are stable for 12 months after receipt.
• For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.